In this episode, Jonathan W. Friedberg, MD; Alex F. Herrera, MD; and Kara Kelly, MD, discuss the latest frontline treatment options for advanced Hodgkin lymphoma (HL) and approaches to personalizing treatment for the general patient population, older patients, and pediatric patients. This podcast was adapted from a live presentation held in May 2025. The Landscape of Frontline Options in HL Special Considerations for Older Patients Special Considerations for Pediatric Patients Future Directions in HL Presenters: Jonathan W. Friedberg, MD Director, Wilmot Cancer Institute Samuel Durand Professor of Medicine and Oncology University of Rochester Rochester, New York Alex F. Herrera, MD Chief, Division of Lymphoma Professor, Department of Hematology and Hematopoietic Cell Transplantation Medical Director of the City of Hope Clinical Trials Office Associate Medical Director of the Briskin Center for Clinical Research City of Hope Medical Center Duarte, California Kara M. Kelly, MD Waldemar J. Kaminski Endowed Chair of Pediatrics Roswell Park Comprehensive Cancer Center Division Chief and Professor of Pediatrics University at Buffalo Jacobs School of Medicine and Biomedical Sciences Buffalo, New York Content based on an online CME program supported by an independent educational grant from Bristol Myers Squibb. Link to CME: Claim Credit https://bit.ly/3TQ0M45 Link to full program: https://bit.ly/4eV8AuW Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
